Back to Search
Start Over
Discerning the role of polymicrobial biofilms in the ascent, prevalence, and extent of heteroresistance in clinical practice
- Source :
- Repositório Científico de Acesso Aberto de Portugal, Repositório Científico de Acesso Aberto de Portugal (RCAAP), instacron:RCAAP
- Publication Year :
- 2021
-
Abstract
- Antimicrobial therapy is facing a worrisome and underappreciated challenge, the phenomenon of heteroresistance (HR). HR has been gradually documented in clinically relevant pathogens (e.g. Pseudomonas aeruginosa, Staphylococcus aureus, Burkholderia spp., Acinetobacter baumannii, Klebsiella pneumoniae, Candida spp.) towards several drugs and is believed to complicate the clinical picture of chronic infections. This type of infections are typically mediated by polymicrobial biofilms, wherein microorganisms inherently display a wide range of physiological states, distinct metabolic pathways, diverging refractory levels of stress responses, and a complex network of chemical signals exchange. This review aims to provide an overview on the relevance, prevalence, and implications of HR in clinical settings. Firstly, related terminologies (e.g. resistance, tolerance, persistence), sometimes misunderstood and overlapped, were clarified. Factors generating misleading HR definitions were also uncovered. Secondly, the recent HR incidences reported in clinically relevant pathogens towards different antimicrobials were annotated. The potential mechanisms underlying such occurrences were further elucidated. Finally, the link between HR and biofilms was discussed. The focus was to recognize the presence of heterogeneous levels of resistance within most biofilms, as well as the relevance of polymicrobial biofilms in chronic infectious diseases and their role in resistance spreading. These topics were subject of a critical appraisal, gaining insights into the ascending clinical implications of HR in antimicrobial resistance spreading, which could ultimately help designing effective therapeutic options.<br />This work was supported by the Portuguese Foundation for Science Technology (FCT) under the scope of the strategic funding of UID/BIO/04469/2020 unit BioTecNorte operation [NORTE-01-0145-FEDER-000004] funded by the European Regional Development Fund under the scope of Norte2020–Programa Operacional Regional do Norte. The authors also acknowledge COMPETE2020 FCT for the project POCI-01-0145-FEDER-029,841 and for the Scientific Employment Stimulus 2017 grant [CEECIND/01507/2017] (A. M. Sousa).<br />info:eu-repo/semantics/publishedVersion
- Subjects :
- 0301 basic medicine
030106 microbiology
medicine.disease_cause
Polymicrobial biofilms
Bacterial Physiological Phenomena
Applied Microbiology and Biotechnology
Microbiology
03 medical and health sciences
Antibiotic resistance
Drug Resistance, Bacterial
Medicine
Animals
Humans
Clinical failure
Science & Technology
biology
Bacteria
business.industry
Pseudomonas aeruginosa
Biofilm
General Medicine
Bacterial Infections
Antimicrobial
biology.organism_classification
3. Good health
Acinetobacter baumannii
Anti-Bacterial Agents
Clinical Practice
030104 developmental biology
Staphylococcus aureus
Biofilms
Immunology
Candida spp
Heteroresistance
Interspecies interactions
business
Subjects
Details
- ISSN :
- 15497828
- Volume :
- 47
- Issue :
- 2
- Database :
- OpenAIRE
- Journal :
- Critical reviews in microbiology
- Accession number :
- edsair.doi.dedup.....67caf973850c5d38850de210ce2f319f